Navigation Links
Aon Construction Services Group Hires Veteran Industry Expert to Lead Hawaii Operations
Date:3/20/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015 Dr. Christopher Asandra, M.D., Founder ... today lamented the FDA’s recent decision to issue ... He argued that FDA’s conclusions are not supported by ... suffer from testosterone deficiency. , “The FDA appears to ... replacement therapy,” said Dr. Asandra. “There is not nearly ...
(Date:3/4/2015)... New York (PRWEB) March 04, 2015 ... ) that allege the statin drug caused patients to ... the U.S. District Court, District of South Carolina. According ... be convened on March 26, 2015 at 10:00 a.m. ... directed to submit a Joint Status report to the ...
(Date:3/4/2015)... March 04, 2015 TROY Healthcare Solutions ... which provides the ultimate level of security for prescriptions, ... Hilton Houston Plaza Medical Center located at 6633 Travis ... Beginning at 7 AM, TROY Healthcare Solutions will host ... Solutions will offer brief presentations each hour to introduce ...
(Date:3/4/2015)... Falls Church, VA (PRWEB) March 04, 2015 ... in Four Hours , **FDAnews Webinar**, March 24, 2015 ... , FDA investigators generally know within four hours ... not. If the manufacturer is on their “good” list, ... they’re doing. If a manufacturer is on the “bad” ...
(Date:3/4/2015)... Cook For Your Life (CFYL), a New ... to people touched by cancer, is launching its first ... by founder Ann Ogden, will be facilitated by Drexel ... partnership will expand the program from its base. , ... After going through her own cancer treatments, Ogden realized ...
Breaking Medicine News(10 mins):Health News:NuMale’s Dr. Christopher Asandra: FDA Suffering from “Premature Equivocation” on Issue of Testosterone and Risks 2Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 2Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 3Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 2Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 4Health News:Drexel University and Cook for Your Life Team Up 2Health News:Drexel University and Cook for Your Life Team Up 3Health News:Drexel University and Cook for Your Life Team Up 4Health News:Drexel University and Cook for Your Life Team Up 5
... enzyme found in the venom of the brown recluse spider, ... discovered a new way to open// molecular pores, called ion ... research team – Zhe Lu, MD, PhD; Yajamana Ramu, PhD; ... at Penn – screened venoms from over 100 poisonous invertebrate ...
... fiber and fruit each day is the key to maintaining ... of examining the diets of 52// normal-weight adults and 52 ... normal weight adults consumed 33 percent more dietary fiber and ... fiber and complex carbohydrates are associated with a lean mass ...
... reported a new outbreak of bird flu among poultry in ... ,The national avian influenza laboratory tested samples and confirmed the ... outbreak that began on July 14 near the town of ... 3,045 chickens died in the outbreak, and agriculture workers culled ...
... approval to an implantable contraceptive called Implanon. The matchstick sized ... and prevents pregnancy for three year after which it may ... said that the implant would release a low but steady ... countries since 1998 and an estimated 2.5 million women have ...
... broad-spectrum IV antibiotic that can be used for the ... caused by antibiotic// resistant bacteria such as methicillin-resistant Staphylococcus ... from today. Availability of this new antibiotic comes at ... is greater than ever and clinicians are running out ...
... hope to use gas bubbles like corks to block oxygen ... process of blocking blood flow to a tumor is called ... embolotherapy. What makes it so promising is that the technique ... so blockage of blood flow to surrounding tissue is minimal, ...
Cached Medicine News:Health News:New Way to Open Cellular Ion Channels, Implications for Drug Design 2Health News:Broad Spectrum Antibiotic Available for Antibiotic Resistant Bacteria 2Health News:Researchers Use Bubbles in Cancer Treatment and Drug Delivery 2
(Date:3/4/2015)... -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... II proof of concept clinical study investigating the ... in the treatment of chronic pruritus in patients ... clinically meaningful improvement from baseline by tradipitant (40.5mm ... 100mm unit Visual Analog Scale (VAS) for itch, ...
(Date:3/4/2015)...  The strongest driver of demand in the ... population, according to Kalorama Information. The finding was ... market research publisher, Global Orthopedic Device Market ... such as obesity is contributing to the rise ... designs and the trend toward cost effective solutions ...
(Date:3/4/2015)... 4, 2015 China Biologic Products, Inc. (NASDAQ: ... integrated plasma-based biopharmaceutical company in China, today announced its ... 2014. Fourth Quarter 2014 Financial Highlights ... of 2014 increased by 36.2%, or 36.8% excluding the ... million from $42.6 million in the same quarter of ...
Breaking Medicine Technology:Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 3Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 4Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 5Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 6Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 7Kalorama: Growing Elderly Population Drives Orthopedic Device Market 2Kalorama: Growing Elderly Population Drives Orthopedic Device Market 3China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 2China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 3China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 4China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 5China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 6China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 7China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 8China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 9China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 10China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 11China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 12China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 13China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 14China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 15China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 16China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 17China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 18China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 19China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 20China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 21China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 22
... the leading public medical equipment marketplace, and the leader ... has launched its Certified Parts Vendor (CPV) Program. ... parts vendors, provide enhanced vendor due diligence and create ... CPV Program is create stronger direct buyer-seller relationships. , ...
... 8 Endologix, Inc. (Nasdaq: ELGX ), developer of ... has become aware that Cook Medical has filed a lawsuit ... Endologix infringes two of Cook,s U.S. patents. , John McDermott, ... become aware of the lawsuit filed by Cook alleging that ...
Cached Medicine Technology:DOTmed Announces Certified Parts Vendor (CPV) Program 2Endologix Comments on Alleged Patent Infringement 2
... treat heart rhythms that are abnormally fast ... often are used to treat sudden cardiac ... reduce the SCD mortality rate for these ... to less than 2 percent as verified ...
... Frequency Ultrasound system is the most advanced ... available. The HF35-50 allows users to perform ... segment with 35MHz or 50MHz probes or ... 20 MHz sealed B-probe. , ,The Macintosh ...
Sonogage introduces a new generation of A-Scan biometers for visual axis measurements and IOL calculations. The Eye-Scan™ employs the latest electronic and transducer technologies for unsurpass...
... display and IOL power calculation software. All ... module with SRK II, SRKT, Holladay Dioptimum ... 5000e and DGH 5100e are equipped with ... of short readings. The only A-Scan in ...
Medicine Products: